drugset / Trial / NCT00969787

DWP05195 in Healthy Adult Male Volunteers

NCT00969787 ↗

Phase 1 Completed 80 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedSingle-groupDouble-blind

Summary

The purpose of this study is to evaluate safety, tolerability, pharmacokinetics and pharmacodynamics of orally administrated DWP05195 in healthy male volunteers.

Timeline

Start
2009-04
Primary completion
2009-11
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject DWP05195 Small molecule — Oral

Indications

No indication recorded.